158 related articles for article (PubMed ID: 21252057)
1. Novel approaches and future directions in castration-resistant prostate cancer.
Nabhan C; Parsons B; Touloukian EZ; Stadler WM
Ann Oncol; 2011 Sep; 22(9):1948-1957. PubMed ID: 21252057
[TBL] [Abstract][Full Text] [Related]
2. The role of IMiDs alone or in combination in prostate cancer.
Nabhan C; Petrylak DP
Clin Genitourin Cancer; 2012 Sep; 10(3):141-6. PubMed ID: 22608152
[TBL] [Abstract][Full Text] [Related]
3. Lessons from in-vivo models of castration-resistant prostate cancer.
Lin D; Gout PW; Wang Y
Curr Opin Urol; 2013 May; 23(3):214-9. PubMed ID: 23385975
[TBL] [Abstract][Full Text] [Related]
4. Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer.
MacVicar GR; Hussain MH
Curr Opin Oncol; 2013 May; 25(3):252-60. PubMed ID: 23511665
[TBL] [Abstract][Full Text] [Related]
5. Using surrogate biomarkers to predict clinical benefit in men with castration-resistant prostate cancer: an update and review of the literature.
Armstrong AJ; Febbo PG
Oncologist; 2009 Aug; 14(8):816-27. PubMed ID: 19684076
[TBL] [Abstract][Full Text] [Related]
6. Novel therapeutic approaches for the treatment of castration-resistant prostate cancer.
Heidegger I; Massoner P; Eder IE; Pircher A; Pichler R; Aigner F; Bektic J; Horninger W; Klocker H
J Steroid Biochem Mol Biol; 2013 Nov; 138():248-56. PubMed ID: 23792785
[TBL] [Abstract][Full Text] [Related]
7. The changing therapeutic landscape of castration-resistant prostate cancer.
Yap TA; Zivi A; Omlin A; de Bono JS
Nat Rev Clin Oncol; 2011 Aug; 8(10):597-610. PubMed ID: 21826082
[TBL] [Abstract][Full Text] [Related]
8. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
[TBL] [Abstract][Full Text] [Related]
9. New therapeutic strategies for castration-resistant prostate cancer.
Tanaka T; Nakatani T
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):373-83. PubMed ID: 21612574
[TBL] [Abstract][Full Text] [Related]
10. Novel chemotherapies in development for management of castration-resistant prostate cancer.
Tewari AK; George DJ
Curr Opin Urol; 2013 May; 23(3):220-9. PubMed ID: 23511791
[TBL] [Abstract][Full Text] [Related]
11. Androgen annihilation as a new therapeutic paradigm in advanced prostate cancer.
Rove KO; Crawford ED
Curr Opin Urol; 2013 May; 23(3):208-13. PubMed ID: 23492838
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of castration-resistant prostate cancer progression.
Dutt SS; Gao AC
Future Oncol; 2009 Nov; 5(9):1403-13. PubMed ID: 19903068
[TBL] [Abstract][Full Text] [Related]
13. New therapies for castration-resistant prostate cancer: efficacy and safety.
Beltran H; Beer TM; Carducci MA; de Bono J; Gleave M; Hussain M; Kelly WK; Saad F; Sternberg C; Tagawa ST; Tannock IF
Eur Urol; 2011 Aug; 60(2):279-90. PubMed ID: 21592649
[TBL] [Abstract][Full Text] [Related]
14. New therapies for castrate-resistant prostate cancer.
Williams SB; Lay AH; Lau CS; Josephson DY; Wilson TG; Choueiri TK; Pal SK
Expert Opin Pharmacother; 2011 Sep; 12(13):2069-74. PubMed ID: 21663529
[TBL] [Abstract][Full Text] [Related]
15. Novel agents for the management of castration-resistant prostate cancer.
Haddad H; Garcia JA
Curr Opin Urol; 2012 May; 22(3):175-82. PubMed ID: 22472509
[TBL] [Abstract][Full Text] [Related]
16. Moving toward personalized medicine in castration-resistant prostate cancer.
Van Allen EM; Pomerantz M
Urol Clin North Am; 2012 Nov; 39(4):483-90. PubMed ID: 23084525
[TBL] [Abstract][Full Text] [Related]
17. [The treatment of castration-resistant prostate cancer].
Petrányi Á
Magy Onkol; 2012 Dec; 56(4):219-28. PubMed ID: 23236591
[TBL] [Abstract][Full Text] [Related]
18. Progress in the treatment of advanced prostate cancer.
Sternberg CN; Petrylak DP; Madan RA; Parker C
Am Soc Clin Oncol Educ Book; 2014; ():117-31. PubMed ID: 24857068
[TBL] [Abstract][Full Text] [Related]
19. Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.
Chi KN; Bjartell A; Dearnaley D; Saad F; Schröder FH; Sternberg C; Tombal B; Visakorpi T
Eur Urol; 2009 Oct; 56(4):594-605. PubMed ID: 19560857
[TBL] [Abstract][Full Text] [Related]
20. Current and emerging treatments in the management of castration-resistant prostate cancer.
Shapiro D; Tareen B
Expert Rev Anticancer Ther; 2012 Jul; 12(7):951-64. PubMed ID: 22845410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
